Funding
Our funders include Action Medical Research, BMA, BBSRC, Cystic Fibrosis Trust, JPIAMR, Horizon 2020 European Commission, Innovate UK, Meningitis now, MRC, NIH and Wellcome Trust.
| Funder | Project |
|---|---|
| Cystic Fibrosis Trust. 2021-2025 | An evidence-based preclinical framework for the development of antimicrobial therapeutics in cystic fibrosis |
| Horizon 2020 Research and Innovation Framework Programme. 2021-2025 | Inhalable Aerosol Light Source for Controlling Drug Resistant Bacterial Lung Infections |
| BBSRC Project Grant. 2021 – 2024 | Does CRISPR-Cas immunity limit the effectiveness of phage therapy? |
| NIH SF 424 (R&R) Grant. 2021 - 2023 | Biofilm disrupting antibody to treat respiratory infections |
| BBSRC Project Grant. 2021-2022 | In Vitro Organ Imaging Device (IV-OID) with integrated Biosensing and Real-Time Imaging Capability: Proof-of-Principle using a Human Placental Model |
| Innovate UK. 2020-2022 | SPOR-COV: Prophylaxis of COVID-19 using Innate Immunity |
| MRC Programme Grant. 2017–2022 | The role of immune tolerance and regulation in pneumococcal carriage and invasive disease. |
| British Medical Association Foundation. 2019-2022 | Immune profiling and high-throughput taxonomic analysis of the nasopharyngeal microbiota of infants presenting with acute viral respiratory tract infection |
